• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICMO 12.6
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Toxic Anterior Segment Syndrome (TASS) (4469)
Type of Reportable Event Serious Injury
Event or Problem Description
The reporter indicated that the surgeon implanted a 12.6mm vticmo -16.00/+3.00/071 implantable collamer lens into a left eye (os) on (b)(6) 2024.Concomitant products used intraoperatively include the msi injector delivery system.Tass was reported.No diagnostic cultures were performed.The patient was prescribed steroid eye drop treatment to resolve the issue.The lens remains implanted.The reporter does not state a cause for the event.Additional information has been requested but none has been forthcoming.If additional information is received a supplemental medwatch report will be submitted.
 
Additional Manufacturer Narrative
A4-a6: unk.H6 - type of investigation: 4110 - lens work order search: no similar complaint type events reported for units within the same lot.Manufacture narrative: a review of the device labeling was completed.Severe intraocular inflammation is identified in the labeling as a known potential adverse event following icl implantation.The dfu states precautions to physicians (3): the lens must not be exposed to any solution other than normally used intraocular perfusion fluids (e.G., isotonic saline, bss, viscoelastic solutions, etc.).An inflammatory response is common after intraocular surgery; however, this is usually mild and does not require any additional interventions beyond the standard post-op regimen.In some cases, the degree of inflammation may be more severe.Toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with severe post-op inflammation, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also be a contributing factor.It should be noted multiple cases of similar clinical presentation were reported from the same facility under the same surgeon.An exact cause could not be determined as the issue resolved and the lens remains implanted.The event could be multifactorial in nature including patient and/or procedure related factors.Claim #(b)(4).
 
Additional Manufacturer Narrative
H3 - device evaluation 3331 - device history record (dhr) review - the device history records indicates that the product has been manufactured within the established process parameters and that there is no indication that the manufacturing and/or processing of the device contributed to the complaint issue.Claim # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Common Device Name
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key20333259
Report Number2023826-2024-04350
Device Sequence Number15413054
Product Code QCB
UDI-Device Identifier00840311323869
UDI-Public(01)00840311323869(11)231012(17)260930
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2026
Device Model NumberVTICMO 12.6
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/05/2024
Supplement Date Received by Manufacturer12/23/2024
Initial Report FDA Received Date09/30/2024
Supplement Report FDA Received Date12/31/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/12/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CARTRIDGE MODEL: SFC-45 - LOT# UNK; CARTRIDGE MODEL: SFC-45 - LOT# UNK; INJECTOR MODEL: MSI-PF - LOT# UNK
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-